600511 國藥股份
按盤價 
34.630 +0.080 (+0.232%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 9.148 | 14.311 | 14.551 | 14.482 | 12.581 |
| 總資產報酬率 ROA (%) | 4.436 | 6.916 | 6.817 | 6.630 | 5.632 |
| 投入資產回報率 ROIC (%) | 7.280 | 11.294 | 11.487 | 11.621 | 10.153 | 邊際利潤分析 |
| 銷售毛利率 (%) | 7.018 | 8.031 | 8.401 | 7.814 | 7.783 |
| 營業利潤率 (%) | 5.231 | 5.925 | 5.923 | 5.267 | 4.738 |
| 息稅前利潤/營業總收入 (%) | 4.976 | 5.644 | 5.844 | 5.222 | 4.732 |
| 淨利潤/營業總收入 (%) | 4.141 | 4.697 | 4.679 | 4.150 | 3.738 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 87.366 | 85.365 | 84.828 | 86.605 | 82.840 |
| 價值變動淨收益/利潤總額(%) | 16.096 | 12.616 | 10.849 | 11.590 | 11.505 |
| 營業外收支淨額/利潤總額(%) | -1.192 | -0.460 | -0.262 | -0.101 | 0.215 | 償債能力分析 |
| 流動比率 (X) | 2.037 | 2.035 | 2.022 | 1.930 | 1.968 |
| 速動比率 (X) | 1.677 | 1.750 | 1.731 | 1.654 | 1.696 |
| 資產負債率 (%) | 46.248 | 45.974 | 46.437 | 48.749 | 47.424 |
| 帶息債務/全部投入資本 (%) | 14.603 | 15.012 | 16.498 | 14.208 | 15.513 |
| 股東權益/帶息債務 (%) | 543.504 | 531.600 | 472.573 | 563.460 | 518.621 |
| 股東權益/負債合計 (%) | 104.588 | 105.737 | 103.384 | 93.595 | 96.890 |
| 利息保障倍數 (X) | -25.685 | -22.238 | -92.200 | -132.292 | -280.550 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 67.817 | 53.260 | 45.326 | 43.226 | 72.981 |
| 存貨周轉天數 (天) | 35.197 | 30.242 | 31.237 | 27.584 | 30.967 |
| 備註： | 即時報價更新時間為 27/11/2024 15:33 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
